RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2017; 49(18): 4327-4334
DOI: 10.1055/s-0036-1589024
DOI: 10.1055/s-0036-1589024
paper
Asymmetric Friedel–Crafts/Michael Reaction of Indoles and Pyrroles with Coumarin-3-carbonylates
This study was performed under financial support of the Russian Science Foundation (Grant 14-23-00186).Weitere Informationen
Publikationsverlauf
Received: 27. März 2017
Accepted: 07. April 2017
Publikationsdatum:
07. Juni 2017 (online)
Abstract
Asymmetric Friedel–Crafts reactions of indoles or pyrroles with coumarin-3-carboxylates catalyzed by Cu(OTf)2 complexes with chiral bis(oxazoline) ligands have been developed. The highest ee (up to 82%) was achieved for indole with a nitro derivative of coumarin-3-carboxylate.
Key words
enantioselective catalysis - BOX ligands - copper - 3,4-dihydrocoumarins - asymmetric Friedel–Crafts reactionSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0036-1589024.
- Supporting Information
-
References
- 1a Evans BE. Rittle KE. Bock MG. Dipardo RM. Freidinger RM. Whitter WL. Lundell GF. Veber DF. Anderson PS. Chang RS. L. Lotti VJ. Cerino DJ. Chen TB. Kling PJ. Kunkel KA. Springer JP. Hirshfield J. J. Med. Chem. 1988; 31: 2235
- 1b Horton DA. Bourne GT. Smythe ML. Chem. Rev. 2003; 103: 893
- 1c Gompel M. Leost M. Joffe EB. D. Puricelli L. Franco LH. Palermo J. Meijer L. Bioorg. Med. Chem. Lett. 2004; 14: 1703
- 1d Radwan MA. A. El-Sherbiny M. Bioorg. Med. Chem. 2007; 15: 1206
- 1e Takahashi S. Matsunaga T. Hasegawa C. Saito H. Fujita D. Kiuchi F. Tsuda Y. Chem. Pharm. Bull. 1998; 46: 1527
- 1f Naik SR. Harindran J. Varde AB. J. Biotechnol. 2001; 88: 1
- 1g Pettit GR. Knight JC. Herald DL. Davenport R. Pettit RK. Tucker BE. Schmidt JM. J. Nat. Prod. 2002; 65: 1793
- 1h Nishida A. Fuwa M. Fujikawa Y. Nakahata E. Furuno A. Nakagawa M. Tetrahedron Lett. 1998; 39: 5983
- 1i Guella G. Mancini I. Ndiaye I. Pietra F. Helv. Chim. Acta 1994; 77: 1999
- 1j N’Diaye I. Guella G. Mancini I. Pietra F. Tetrahedron Lett. 1996; 37: 3049
- 1k Roelens F. Huvaere K. Dhooge W. Van Cleemput M. Comhaire F. De Keukeleire D. Eur. J. Med. Chem. 2005; 40: 1042
- 1l Kumar A. Singh BK. Tyagi R. Jain SK. Sharma SK. Prasad AK. Raj HG. Rastogi RC. Watterson AC. Parmar VS. Bioorg. Med. Chem. 2005; 13: 4300
- 1m Modranka J. Albrecht A. Jakubowski R. Krawczyk H. Rozalski M. Krajewska U. Janecka A. Wyrebska A. Rozalska B. Janecki T. Bioorg. Med. Chem. 2012; 20: 5017
- 1n Yang J. Liu GY. Dai F. Cao XY. Kang YF. Hu LM. Tang JJ. Li XZ. Li Y. Jin XL. Zhou B. Bioorg. Med. Chem. Lett. 2011; 21: 6420
- 1o Tyrrell E. Mazloumi K. Banti D. Sajdak P. Sinclair A. Le Gresley A. Tetrahedron Lett. 2012; 53: 4280
- 2a Ye MC. Yang YY. Tang Y. Sun XL. Ma Z. Qin WM. Synlett 2006; 1240
- 2b Nickerson DM. Mattson AE. Chem. Eur. J. 2012; 18: 8310
- 2c Kumar A. Kumar P. Tripathi VD. Srivastava S. RSC Adv. 2012; 2: 11641
- 2d Oelerich J. Roelfes G. Org. Biomol. Chem. 2015; 13: 2793
- 2e Tan F. Li F. Zhang XX. Wang XF. Cheng HG. Chen JR. Xiao WJ. Tetrahedron 2011; 67: 446
- 2f Shao ZZ. Xu LB. Wang L. Wei HT. Xiao J. Org. Biomol. Chem. 2014; 12: 2185
- 2g Jennings JJ. Bhatt CP. Franz AK. J. Org. Chem. 2016; 81: 6211
- 3 Prabhakar M. Reddy GN. Srinu G. Manjulatha K. Prasad JV. Kumar SP. Srinivas O. Iqbal J. Kumar KA. Synlett 2010; 947
- 4 Zhou QL. Privileged Chiral Ligands and Catalysts. Wiley; New York: 2011
- 5a Yamamoto H. Lewis Acids in Organic Synthesis . Wiley-VCH; Weinheim: 2008. p 99
- 5b Desimoni G. Faita G. Jørgensen KA. Chem. Rev. 2006; 106: 3561
- 5c Johnson JS. Evans DA. Acc. Chem. Res. 2000; 33: 325
- 5d Desimoni G. Faita G. Quadrelli P. Chem. Rev. 2003; 103: 3119
- 5e Rasappan R. Laventine D. Reiser O. Coord. Chem. Rev. 2008; 252: 702
- 5f Beletskaya IP. Averin AD. Curr. Organocat. 2016; 3: 60
- 6 Desyatkin VG. Anokhin MV. Rodionov VO. Beletskaya IP. Russ. J. Org. Chem. 2016; 52: 1719